Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery
NOTES
Prospective Evaluation of the Intraoperative Use of Translumenal Flexible Endoscopes During Combined Flexible and Laparoscopic Foregut and Urologic Surgery
1 other identifier
interventional
11
1 country
1
Brief Summary
NOTES access is safe and feasible in the controlled human setting and comparable to standard-of-care surgical techniques. NOTES exploration of the abdomen provides adequate visualization comparable to laparoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 7, 2007
CompletedFirst Posted
Study publicly available on registry
June 11, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2009
CompletedDecember 16, 2014
December 1, 2014
2.4 years
June 7, 2007
December 12, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30 day Post-op NOTES feasibility outcomes:
* Number of successful NOTES access attempts * Number of failed NOTES access attempts * Injury to collateral organs or structures * Time to gain access to peritoneal cavity * Necessary balloon dilator size required for translumenal passage of endoscope
30 days post-op
Secondary Outcomes (2)
30 Day Post-OP Evaluation of Efficacy of NOTES access when compared to historical control groups undergoing laparoscopic access during foregut surgery
30 Day Post-OP
30 Day NOTES Post - Op Evaluation of Adequacy of Abdominal Exploration
30 Day Post - Op
Study Arms (2)
Prospective
EXPERIMENTALSubjects scheduled to receive procedure
Historical
OTHERChart review control group
Interventions
Patients will have the standard laparoscopic procedure and the NOTES procedure will be added. The surgical procedure will require two operating teams: one led by a laparoscopic surgeon, the other by an endoscopic surgeon. During the usual course of the surgery, the flexible endoscope will be passed through the mouth urethra top gain access to the peritoneal cavity.
chart review of historical data from control group
Eligibility Criteria
You may qualify if:
- Patients undergoing an already combined laparoscopic and endoscopic foregut procedure with general anesthesia
- Patients undergoing a prostatectomy or cystectomy with general anesthesia
- All patients will have a planned gastrotomy for exploration, foreign body removal, or removal of tissue, making it a contaminated case or a planned cystotomy or urethrotomy for exploration, foreign body removal or removal of tissue such as prostatectomy or bladder resection.
- No overwhelming medical co-morbidities
- Subject is 18 years of age or older
- Subject is his or her own medical decision maker
- Subject agrees to participate, fully understands content of informed consent form, and signs the informed consent form
You may not qualify if:
- Patients undergoing a non-palliative procedure in the face of resectable adenocarcinoma of the foregut or genitourinary tract
- Linitis Plastica
- Evidence of Active Bowel Obstruction
- Patients with history of oropharyngeal, esophageal, or gastric adenocarcinoma.
- Esophageal stricture prohibiting passage of an endoscope
- Urethral stricture prohibiting passage of an endoscope
- Emergent Surgery
- At any time during pre-operative or intra-operative periods, evidence of unresectability is demonstrated
- Any intra-operative condition prior to surgical resection that results in abortion of the surgical procedure
- Any contraindication to surgery
- Pregnancy or actively breastfeeding women
- Prisoners or Wards of State
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals of Cleveland Case Medical Center
Cleveland, Ohio, 44116, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey M. Marks, MD
University Hospitals of Cleveland/ Institute for Surgical Innovation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicpal Investigator
Study Record Dates
First Submitted
June 7, 2007
First Posted
June 11, 2007
Study Start
August 1, 2006
Primary Completion
January 1, 2009
Study Completion
January 1, 2009
Last Updated
December 16, 2014
Record last verified: 2014-12